If yours is not, then ask your doctor why. New labeling for both Sporanox and Lamisil recommends that healthcare providers obtain nail specimens for laboratory testing prior to prescribing the medications for onychomycosis to confirm the diagnosis. In these studies, the adverse effect on the heart muscle resolved once the drug was stopped. Death was reported in 13 cases. While adverse liver effects were already included in the labeling for both products, FDA decided to include this information in the advisory because some cases involved patients who had neither pre-existing liver disease nor a serious underlying medical condition.
Tablets are prescription medicines approved to treat toe and finger nail fungal infections.
This Public Health Advisory does NOT apply to these topically applied dosage forms. These labeling changes are based on a safety evaluation of preclinical, clinical and post-marketing information. Although the causal relationship is unclear, death was reported in 13 cases. Based on data known at present, the warning signs are most likely to be present while taking the drug or soon after stopping it. Every single drug that affects the body will have some side effects.